Guest View
User: Pass: | become a member
Posts Tagged ‘SPLS’

PetSmart Puts In Play As Shares Extend Declines

www.interactivebrokers.com

 

Today’s tickers: PETM, FURX & SPLS

PETM - PetSmart, Inc. – Shares in the specialty retailer of products and services for pets and their owners fell sharplythis morning on a downgrade to ‘reduce’ from ‘neutral’ at Nomura, with the stock currently trading 7.4% lower on the session at $64.81 as of 11:25 a.m. ET. A sizable bearish options strategy initiated on PetSmart in the early going suggests one trader is bracing for shares to extend declines during the next couple of months. It looks like the strategist purchased a 2,000-lot March $60/$65 put spread for a net premium of $1.55 per contract. The bearish position starts making money if shares in PETM decline 2.1% from the current price of $64.81 to breach the effective breakeven point at $63.45. Maximum potential profits of $3.45 per contract are available on the spread in the event that shares drop more than 7.4% to settle below $60.00 at April expiration. Two weeks ago we noted a similar bear put spread initiated on PETM; the similar-sized position was an April $60/$65 put spread purchased at a net premium of $1.80 per contract. Both positions result in maximum possible profits if shares in PetSmart drop to $60.00 by expiration in March and April.

FURX - Furiex Pharmaceuticals, Inc. – Shares in Furiex Pharmaceuticals are soaring today, up 52% to stand at $32.33 just before midday in New York, after the company confirmed that its partner, Japanese firm Takeda Pharmaceutical Co., received approval from the U.S. FDA for three new type 2 diabetes therapies designed to treat the disease in adults in combination with diet and exercise. Furiex options, which typically see daily volume of around 33 contracts on average, are far more active than usual on news of the approval, with volume topping 1,685 contracts during the first half of the session. Put options are more active than calls, with roughly two puts in play for each single call option. The stock this morning rallied 55% to an all-time high of $32.97, but had already started making moves to the upside at…
continue reading


Tags: , ,




Bullish Options Build On Biotech Company Gilead Sciences

www.interactivebrokers.com

 

Today’s tickers: GILD, SPLS & ODP

GILD - Gilead Sciences, Inc. – Bullish activity in the biotechnology company’s options jumped and shares in Gilead Sciences moved up more than 2.0% to $46.18 the same day the drug maker presented at the 2012 RBC Capital Markets’ Healthcare Conference in New York. Positive comments from management along with the impending April 19th first-quarter earnings report from the Company could be catalysts for the sizable bull call spreads accumulating in the April expiry. It looks like one investor purchased a roughly 15,000-lot April $47/$50 call spread for a net premium of $1.13 per contract to position for shares to extend gains during the next couple of months. Profits may be available on the spread in the event that Gilead’s shares rally another 4.2% to surpass the average breakeven price of $48.13, while maximum possible profits of $1.87 per contract pad the investor’s wallet should the stock surge 8.3% to top $50.00 at expiration. Gilead’s shares had realized year-to-date gains of 35.0% earlier this month after the Company’s better-than-expected fourth-quarter earnings report sent the stock up as high as $56.50 on the 6th of February. The stock subsequently came back down with a thud shortly after reaching its highest level since 2008, but the options trader responsible for the call activity this morning is poised to benefit should the stock regain its footing in the near term.

SPLS - Staples, Inc. – Shares in the office supplies retailer rallied 4.7% to $15.95 in sympathy with competitor, Office Depot, Inc., which opened sharply higher on better-than-expected fourth-quarter earnings released ahead of the opening bell this morning. Staples is scheduled to reveal its fourth-quarter performance before U.S. markets open on Wednesday, and it looks like options traders are positioning for the upward move in…
continue reading


Tags: , ,




Options Player Harvests Premium, Sells Ralph Lauren Corp. Calls

www.interactivebrokers.com

Today’s tickers: RL, OSK, SPLS & RAX

RL - Ralph Lauren Corp. – The designer of premium-brand lifestyle products ranging from men’s and women’s fashion to fragrances and home furnishings popped up on our ‘hot by options volume’ market scanner after one investor traded a large chunk of deep out-of-the-money October contract call options. Shares in Ralph Lauren Corp. fell 2.0% earlier in the session to $135.69, but recovered in early-afternoon trade to stand roughly flat on the session at $138.82 as of 12:20 pm ET. The stock currently trades a few dollars below its July 21 all-time high of $141.37. The strategist responsible for nearly all of the options volume on Ralph Lauren today appears to be taking the view that the price of the underlying shares are unlikely to soar above $155.00 within the next five weeks to October expiration. More than 9,900 call options changed hands at the October $155 strike against paltry previously existing open interest of just 372 contracts. One block of 9,075 of those calls were sold by one investor at a premium of $1.70 a-pop within the first hour of the trading session. The trader selling the calls keeps the full amount of premium received on the transaction as long as shares in Ralph Lauren fail to exceed $155.00 come expiration day. The investor may be selling the calls outright, or could be writing the options against an existing long position in the underlying shares. In the naked short scenario, the strategist may accrue losses on the position in the event that RL’s shares jump 12.9% over the current price of $138.82 to surpass the effective breakeven price of $156.70. Options implied volatility on the stock dropped 5.05% this afternoon to 46.3%. Ralph Lauren reports second-quarter earnings on November 9, 2011, well after October options expiration.…
continue reading


Tags: , , ,




Investors Peruse Kohl’s Options

www.interactivebrokers.com

Today’s tickers: KSS, AEP, FCX & SPLS

KSS - Kohl’s Corp. – The department store operator’s shares jumped 4.25% this afternoon to an intraday high of $55.90 following the company’s first-quarter earnings release ahead of the open this morning. Kohl’s Corp. raised its full-year profit forecast to a range of $4.25 to $4.40 a share, which tops average analyst estimates of around $4.36 a share. Some strategists browsing through Kohl’s options today are positioning for the stock to extend gains, while others could be taking profits on pre-earnings positions or taking a more bearish stance on the stock in the near term. Traders picked up around 2,200 now in-the-money calls at the May $55 strike for an average premium of $0.47 each. Call buyers at this strike make money if shares in KSS exceed the average breakeven price of $55.47 through expiration next week. Meanwhile, put and call selling took place in the June contract. Traders sold roughly 1,160 calls at the June $52.5 strike for an average premium of $3.10 each, and shed 1,900 calls up at the June $55 strike at a premium of $1.40 apiece. Open interest in the June $52.5 strike calls suggests investors bought some 5,090 calls at that strike for an average premium of $1.68 each back on April 26. Traders selling the now deep in-the-money calls could be cashing in on their well-placed bullish positions. On Tuesday, around 1,000 calls were picked up at the June $55 strike for an average premium of $0.70 each. The subsequent rally in the price of the underlying has these contracts trading with an asking price of $1.70 per contract as of 2:15pm. Volume of 2,200 calls at the June $55 strike exceeds open interest of 1,592 contracts. Nearly all of the calls exchanged at that strike sold for an average premium of $1.40 each. Perhaps call sellers see shares in Kohl’s trading below $55.00 at expiration in June. Put players sold around 2,000 contracts at the June $52.5 strike…
continue reading


Tags: , , ,




Three-Legged Bull Prepares for a PNC Rally

www.interactivebrokers.com

Today’s tickers: PNC, CEDC, SPLS & GILD

PNC - PNC Financial Services Group, Inc. – Shares in the financial services firm are down 1.00% at $60.34 in early-afternoon trade, but activity in May contract call and put options suggests one strategist sees shares in PNC rising sharply in the next few months. The three-legged bullish player appears to have sold 5,000 puts at the May $55 strike for a premium of 1.39 each, purchased the same number of calls at the May $62.5 strike for a premium of $2.15 per contract, and shed 5,000 calls up at the May $67.5 strike at a premium of $0.68 a-pop. The options trader paid a net premium of $0.08 per contract for the transaction, and stands ready to profit should PNC’s shares reverse course and rally 3.7% over the current price of $60.34 to exceed the average breakeven price of $62.58 by expiration day in May. The investor responsible for the trade could accumulate maximum potential profits of $4.92 per contract if the firm’s shares jump 11.9% to trade above $67.50 before the options expire. PNC’s shares last traded above $67.50 back in May 2010. The financial services provider reports first-quarter earnings before the opening bell on April 21, 2011.

CEDC - Central European Distribution Corp. – Near-term options activity on the vodka producer this morning suggests some investors expect the pain of Central European Distribution Corp.’s post-earnings hangover to stick around through March expiration. Shares in CEDC lost 11.2% today to trade at $12.38, the lowest recorded price for the stock since April 2009. The alcohol beverage provider’s shares dropped 45.8% during the trading week, from a closing price of $22.85 on Monday, to today’s low of $12.38. Put buyers in the March contract, however, do not seem to think CEDC has hit…
continue reading


Tags: , , ,




Bullish Players Pick Up Calls at Staples Ahead of Earnings

www.interactivebrokers.com

Today’s tickers: SPLS, MRVL, FRX & ERIC

SPLS - Staples, Inc. – Call options on the office supplies retailer are flying off the shelves ahead of the firm’s fourth-quarter earnings report, which is slated for release before the opening bell tolls on Wednesday. Shares in the name are up 1.35% to stand at $21.22 as of 12:00pm in New York. Bullish players are out in numbers, buying up call options in the March and April contracts, to position for shares to extend gains in the near term. Meanwhile, there is a bit of put buying in the front month this morning, with some 1,200 March $21 puts picked up by pessimistic traders for an average premium of $0.55 each. The largest bullish bet on Staples was the purchase of 9,000 calls at the March $22 strike at a premium of $0.40 each. The transaction appears to be tied to the sale of 270,000 shares of the underlying at $21.11 each. The strategy is likely a delta neutral play, with a delta of 0.30 indicated by the size of the stock and option combination employed. The trader could make out on the short stock leg of the trade if shares in SPLS drop post-earnings, however, the parameters of the transaction indicate substantially higher potential gains if shares fly higher in the time remaining to March expiration. A total of 11,395 calls changed hands at the March $22 strike in early-afternoon trade versus previously existing open interest of just 1,520 contracts. Like-minded optimists looked to the April $22 strike to buy roughly 2,000 calls for an average premium of $0.55 per contract. Call buyers at the April $22 strike start making money in the event that Staples’ shares surge 6.3% to surpass the average breakeven price of $22.55 by April expiration. Options implied volatility on the office supplies firm is up 4.8% at 30.82% as of 12:15pm.…
continue reading


Tags: , , ,




Bearish Player Initiates Ratio Put Spread at Staples

www.interactivebrokers.com

Today’s tickers: SPLS, XCO, THC, FTO, YHOO, ERTS, LNC & GE

SPLS - Staples, Inc. – The supplier of office products popped up on our ‘hot by options volume’ market scanner late in the trading session after one investor initiated a bearish spread in the December contract. Staples’ shares are currently down 0.80% at $20.64 as of 3:15 p.m. in New York. The pessimistic player established a ratio put spread, buying 2,500 in-the-money puts at the December $21 strike for an average premium of $1.185 each, and selling 5,000 puts at the lower December $19 strike at an average premium of $0.39 apiece. The average net cost of the transaction amounts to $0.405 per contract. Thus, the investor is prepared to make money if the price of the underlying stock slips beneath the effective breakeven point on the spread at $20.595 by expiration day in December. Maximum potential profits of $1.595 per contract are available to the ratio-spreader if the office products company’s shares fall 7.945% from the current price of $20.64 to settle at $19.00 at expiration. The investor is vulnerable to losses in the event that Staples’ shares plummet far lower than he expects they will in the next several months. Losses start to accumulate for the trader if shares drop 15.7% lower and trade below the lower breakeven point at $17.405 by expiration day. Staples, Inc. is slated to report third-quarter earnings ahead of the opening bell on November 18, 2010.

XCO - EXCO Resources, Inc. – The oil and natural gas company was visited by one long-term bullish options investor in the second half of the trading session. It looks like the trader is expecting EXCO’s shares to rally significantly by expiration day in March of 2011. Shares of the Dallas, TX-based firm are up 2.05% at…
continue reading


Tags: , , , , , , ,




 
 
 

Chart School

Today’s Market and Economists’ Forecasts for 10-Year Yields and the FFR

Courtesy of Doug Short.

As I type this, the market is exhibiting some bipolar disorder following multiple doses of Fed speak: Yesterday Bullard's presentation in Germany and Dudley's speech in New York, and today Bernanke's congressional testimony at 10 AM and the latest Fed Minutes at 2 PM.

Amidst the market confusion, I took a few minutes to review the Wall Street Journal's May survey of economists to see what they had forecast for the 10-year yield and the Fed Funds Rate out to December 2015. The survey was conducted May 3-7 and 48 economists responded, altho...



more from Chart School

Zero Hedge

180 Seconds After The FOMC Release, Hilsenrath Parses Fed Minutes

Courtesy of ZeroHedge. View original post here.

Submitted by Tyler Durden.

What is 410 words and is released precisely 180 seconds after the FOMC's minutes? Why Jon Hilsenrath's FOMC minute-parsing piece of course. Which we can only assume means Jon was on the "preapproved" list for early distribution and pre-analysis, because not even we can analyze and type that fast. We are confident he did not breach the embargo. Because that would not look good for the Fed already being investigated by the Inspector General for last month's humilating breach.

So what did Hilsy ...



more from Tyler

All About Trends

Mid-Day Update

Reminder: David is available to chat with Members, comments are found below each post.

Click here for the full report.




To learn more, sign up for David's free newsletter and receive the free report from All About Trends - "How To Outperform 90% Of Wall Street With Just $500 A Week." Tell David PSW sent you. - Ilene...

more from David

Phil's Favorites

Tim Cook's Improbable Victory In Washington

Lawmakers questioned Apple's CEO Tim Cook on tax matters yesterday. Felix Salmon explains (below) the details of the complicated tax scheme involving subsidiaries in Ireland and various contractual relationships that are legal but devised to lower the corporations' taxes.

And, why not? Since when do corporations live to maximize taxes and minimize profits? What CEO would survive that sort of behavior?

Apple's method of avoiding US taxes is a good argument for eliminating corporate taxes altogether. What do you think?

Tim Cook's Improbable Victory In Washington

By Felix Salmon

W...



more from Ilene

Market Montage

History Being Made

Submitted by Mark Hanna

Courtesy of MarketMontage. View original post here.

One runs out of superlatives to describe the current market.

Every day or week a new record seems to be set.   A few of the current – yesterday was the 19th Tuesday in a row that the DJIA was up; the DJIA is now guaranteed to go without a 3 day losing streak for 100 days, breaking the 95 day record in 1927, the NASDAQ has had 17 days in a row of a new higher high, the best since Nov 1999, etc etc.  Meanwhile Japan is in the realm of 50% YTD gains as their currency is kicked in the teeth.

Definitely an era to keep in our memory banks as the action is abnormal.

Mr. Dudley (NY Fed) spoke yesterday and soun...



more from Mark

Insider Scoop

Intuit Earnings Beat Estimates; Company Updates Full-Year Guidance

Courtesy of Benzinga.

Intuit (NASDAQ: INTU) released its fiscal third-quarter earnings after the closing bell on Tuesday.

The company reported revenues which were in-line with expectations and a profit which beat analysts' estimates. In late trade, shares were up a little less than one percent to $58.31.

The company reported net income of $822 million or $2.71 per share, compared to $734 million or $2.42 per share, in the year ago period.

On an adjusted basis, net income rose to $901 million or $2.97 per share, versus $763 million or $2.52 per share, in last year's third-quarter. This came in ahead of Wall S...



http://www.insidercow.com/ more from Insider

Option Review

Pre-Earnings Bullish Bets On Saks Pay Off As Retailer Rallies

 

Today’s tickers: SKS, HLF & ABFS

SKS - Saks, Inc. – High-end retailer, Saks, Inc., popped up on our ‘hot by options volume’ market scanner this morning on heavier than usual trading traffic in upside calls. Shares in Saks are up 10% on Tuesday morning at a new 52-week high of $13.54 after the company posted first-quarter earnings in line with analyst expectations on higher-than-expected quarterly revenue. Shares in Saks are up more than 30% since this time last year. Bullish positions initiated in SKS options ahead of the earnings release yester...



more from Caitlin

Sabrient

What the Market Wants: No Easy Answer

Courtesy of David Brown, Sabrient Systems and Gradient Analytics

So, what did the market want today?  Nothing it appears.  It traded on weak volume and had very little movement.  This morning the market hated commodities especially silver, but by days end, the market liked silver, gold and even oil but not the dollar.  Why?

Last week the economic reports were tough, with bad misses on more than one occasion.  But the market tended to ignore the bad news, probably because money continues to pour into equities from money market funds, long term fixed income, and many struggling foreign economies.  On Thursday, investors finally caved to even more bad news from Initial Jobless Claims and weak Housing Starts.  Then on Friday, when Michigan Sentiment and Leading Indicators posted large positive surprises, the money came pouring back to generate qui...



more from Sabrient

OpTrader

Swing trading portfolio - week of May 20th, 2013

Reminder: OpTrader is available to chat with Members, comments are found below each post.

This post is for all our live virtual trade ideas and daily comments. Please click on "comments" below to follow our live discussion. All of our current  trades are listed in the spreadsheet below, with entry price (1/2 in and All in), and exit prices (1/3 out, 2/3 out, and All out).

We also indicate our stop, which is most of the time the "5 day moving average". All trades, unless indicated, are front-month ATM options. 

Please feel free to participate in the discussion and ask any questions you might have about this virtual portfolio, by clicking on the "comments" link right below.

To learn more about the swing trading virtual portfolio (strategy, performance, FAQ, etc.), please click here

Optrader 

...

more from OpTrader

Stock World Weekly

Stock World Weekly

NEW: Newsletter writers are available to chat with Members regarding topics presented in SWW, comments are found below each post.

Here's the latest Stock World Weekly! Just sign in with your PSW user name and password, or sign up to try it out. 

...

more from SWW

IRA Strategy/Income Trader

The IRA portfolio

Reminder: Craigzooka is available to chat with Members regarding his virtual portfolio performance, comments are found below each post.

By Craigzooka

I am going to share with you how I manage my IRA and the power of reducing your cost basis.  My goal each year is a 20% return in my IRA.  Sometimes I make it and sometimes I don't, but I believe that all of my success is due to reducing my cost basis.  To illustrate the power of reducing your cost basis here are some trades we did last year.  These trades are taken from an educational portfolio we ran in a paper-trading account for a little more than a year.

  • We bought RIG on 5/15/2012 for $44.13, sold it on 1/18/2013 for $46 but booked a profit of $1,154.
  • We bought MT on 1/4/2012 for $19.24, sold it on 12/21/2012 for $15 but booked a profit of $454.
  • We bought CHK on 1/27/2012 for $21.93, sold it on 10/19/2012 for $18 b...


more from Strategies

ETF Selector

Stock Market Gets Big News After Friday’s Close

Courtesy of John Nyaradi.

Stock market posts another record setting week, but the big news came after Friday’s close.

Courtesy of NASA

The stock market put on another record setting show with the Dow Jones Industrial Average (NYSEARCA:DIA) closing at a record high 15,118 and the S&P 500 (NYSEARCA:SPY) closing at 1633.70, another all time closing high.

For the week, the Dow Jones Industrial Average (NYSEARCA:DIA) gained 1%, the S&P 500 (NYSEARCA:SPY) climbed 1.2%, the Nasdaq Composite (NYSEARCA:...



more from John

Pharmboy

Give Them an Inch, They Will Take a Mile

Reminder: Pharmboy is available to chat with Members, comments are found below each post.

Well, well, well....it is good to know that there are others in the scientific arena who believed that YMI Bioscience's data (cough - Gilead) is a better drug than Incyte's Jakafi.  Now, the definitive data are still unknown, but there was enough evidence from a Phase 2 trial to take a small risk for a huge reward.  So, let's forget about Apple (AAPL), and do nothing but biotechs from now until Congress passes universal health care coverage for prescriptions....and drive the prices down so that research and development is no longer feasible to conduct in the US. Even Seattle Genetics (SGEN) has been on a tear as of late...



more from Pharmboy



FeedTheBull - Top Stock market and Finance Sites



About Phil:

Philip R. Davis is a founder Phil's Stock World, a stock and options trading site that teaches the art of options trading to newcomers and devises advanced strategies for expert traders...

Learn more About Phil >>


As Seen On:




About Ilene:

Ilene is editor and affiliate program coordinator for PSW. She manages the Favorites backup site (blogroll, archives, more). Contact Ilene to learn about our affiliate and content sharing programs.

Favorites Site >>